Scientific publications

The research results are continuously published in related peer-reviewed international scientific journals1. A Review Process serves as a quality control process before publication can be permitted. The publications disseminate information about relevant research to potential stakeholders/licensees.

  1. The hunt for new treatments. Holmberg A. R. Prostate Cancer report in The Times newspaper, 02 December 2008
  2. Bones and prostate cancer. Holmberg A. R. Prostate Cancer report in The Times newspaper, 28 October 2009
  3. A novel somatostatin conjugate with high affinity to all five somatostatin receptor subtypes. U. Wulbrand, M. Feldman, A. Pfestroff, H-C. Fehman, J. Du, J. Hiltunen, M. Marquez, S. Arnold R., Westlin J.E., Nilsson, and A. R. Holmberg. Cancer. 94; 4:1293-1297. Feb 15, 2002.
  4. Phase I trial on sms-D70 somatostatin analogue in advanced prostate and renal cell cancer. Joensuu T.K., Nilsson S, Holmberg A.R., Marquez M, Tenhunen M, Saarto T and Jeonsuu H. Ann. N.Y. Acad Sci.1028:361-371, 2004.
  5. When prostate cancer becomes incurable. Holmberg A.R. Prostate Cancer report in The Times newspaper, 26 October 2010
  6. Treatment of bone metastasis in prostate cancer: efficacy of a novel polybisphosphonate. Daubine F, LE Bot R, Márquez M, Nilsson S, Schröder T, Holmberg AR. Anticancer Research 31:4141-4146, 2011.
  7. Somatostatin effects on the proteome of the LNCaP cell-line. Zhaoxu Liu, Sofia Bengtsson, Morten Krogh, Marcela Marquez, Sten Nilsson, Peter James, Ayodele Aliaya, and Anders R. Holmberg. Int. J. Oncology, 2007.
  8. Polymer-conjugated guanidine is a potentially useful anti-tumor agent. Meurling L, Márquez M, Nilsson S and Holmberg AR. Int J Oncol 35: 281-285, 2009.
  9. Development of a Novel Poly Bisphosphonate Conjugate for Treatment of Skeletal Metastasis and Osteoporosis. Anders R. Holmberg, Ulf H. Lerner, Ayodele Alyia, Mai Al-Mohanna, Chaker Adra, Marcela Marquez, Lennart Meurling, and Sten Nilsson. Int J Oncology, 37, 563-567, 2010.
  10. Application of accelerator mass spectrometry to macromolecules: preclinical pharmacokinetic studies on a polybisphosphonate. Mehran Salehpour, Karl Håkansson, Urban Höglund, Annika Grahn-Westin, Sten Nilsson, Marcela Márquez, Göran Possnert and Anders R. Holmberg. Rapid Commun. Mass Spectrom. 2453-2458, 2011.
  11. Bone-targeted Novel Cytotoxic Polybisphosphonate Conjugate in Castration-resistant Prostate Cancer: A Multicenter Phase 1 Study. Camilla Thellenberg-Karlsson, Claes Nyman, Sten Nilsson, René Blom, Marcela Márquez, Enrique Castellanos and Anders R. Holmberg. ANTICANCER RESEARCH 36: 6499-6504 (2016) doi:10.21873/anticanres.11249
  12. A randomised, double-blind, dose-finding, phase II multicentre study of ODX in the treatment of patients with castration-resistant prostate cancer and skeletal metastases. Camilla Thellenberg-Karlsson, Egils Vyaters, Marju Kase, Teuvo Tammela, Kristiina Ojamaa, Ulf Norming, Claes Nyman, Sven-Olof Andersson, Oleg Hublarovs, Marcela Marquez-Holmberg, Enrique Castellanos, Anders Ullén, Anders Holmberg, Sten Nilsson. European Journal of Cancer 181 (2023) 198e207
  13. Synthesis and Binding of a Novel PSMA-specific Conjugate. Anders R. Holmberg, Marcela Marquez, Lena Lennartsson, Lennart Meurling and Sten Nilsson. Anticancer Res. 38: 1531-1537 (2018) doi:10.21873/anticanres.12381

1 * so-called Peer Review, means that subject experts review the manuscript before possible approval, usually after clarification/modification of the manuscript before publication is allowed